Master's
MSc Cancer Molecular Pathology and Therapeutics – ULi
Course Overview
Leicester’s MSc in Cancer Molecular Pathology and Therapeutics provides a comprehensive foundation in histopathology, molecular diagnostics, targeted cancer therapies, and drug resistance.
The curriculum emphasizes translational research methodologies. Students gain career-ready technical skills for clinical oncology research and drug development.
Entry Requirements
- Academic Records: Certified copy of a recognized bachelor’s degree in Biological Sciences, Medicine, Healthcare, or related quantitative field (minimum 2:1 or 2:2 Honours equivalent / 55-60%+).
- English Proficiency: IELTS Academic 6.5 overall (minimum 6.0 in each subtest), TOEFL iBT 90, or PTE 61.
- Subject Prerequisites: Demonstrated undergraduate background in biosciences, clinical science, genetics, or relevant quantitative modules.
- Additional Tests/Interviews: None standardly required under regular postgraduate direct entry.
- Application Materials: Official degree transcripts, degree completion certificate, statement of purpose, CV/resume, and two academic/professional references.
Career Outcomes
- Molecular Pathologist
- Therapeutic Discovery Scientist
- Oncology Analyst
- Precision Medicine Researcher
- Clinical Trial Manager
Scholarship Available
- Available
Key Information
Location
Leicester, United Kingdom
University
University of Leicester
Intakes
September
Study Mode
On Campus
Tuition Fee
$24,250 / Year
Duration
1 Year
Language
English
Related Courses
York, United Kingdom
University of York
York, United Kingdom
University of York
York, United Kingdom
University of York
York, United Kingdom
University of York
Leicester, United Kingdom
University of Leicester
